CFTR and cystic fibrosis: Median predicted life expectancy in CF patients is currently over 50 years in both UK and US CF populations (6) and is expected to increase even further with the increasing use of CFTR modulator therapy which is now licensed for over 90% of patients with CF in the UK and the US.